Farnesyltransferase

From WikiMD's WELLNESSPEDIA

Farnesyltransferase is an enzyme that plays a crucial role in the post-translational modification of proteins through a process known as prenylation. Specifically, farnesyltransferase catalyzes the attachment of a farnesyl group, a 15-carbon isoprenoid, to the cysteine residue at the C-terminus of certain proteins. This modification is critical for the proper functioning of these proteins, including their localization within cellular membranes and their involvement in signal transduction pathways.

Function[edit]

Farnesyltransferase facilitates the attachment of a farnesyl group to the cysteine residue in the CAAX motif (where C is cysteine, A is an aliphatic amino acid, and X is any amino acid) of target proteins. This enzymatic activity is essential for the post-translational modification known as prenylation, which is crucial for the proper localization and function of the modified proteins. Prenylated proteins are typically involved in important cellular processes such as cell growth, differentiation, and apoptosis.

Structure[edit]

The enzyme is a heterodimer, consisting of an alpha (α) and a beta (β) subunit, which together form the active site where the farnesylation reaction occurs. The structure of farnesyltransferase has been elucidated through X-ray crystallography, revealing insights into its mechanism of action and how it recognizes the CAAX motif of substrate proteins.

Clinical Significance[edit]

Farnesyltransferase inhibitors (FTIs) have been studied extensively as potential therapeutic agents, particularly in the context of cancer treatment. Many oncogenic proteins, such as Ras, require farnesylation for their activity. By inhibiting farnesyltransferase, FTIs can prevent the proper functioning of these proteins, thereby hindering the growth and proliferation of cancer cells. Although the clinical efficacy of FTIs has been variable, research continues into their potential use in treating various malignancies.

See Also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.